Concepedia

Yang Dai

YD

Statistics

Publications

3

Citations

66

H-Index

3

Active since

2015

Affiliations

Alexion Pharmaceuticals (United States)(Current)

Yang Dai is an author at Alexion Pharmaceuticals (United States) specializing in pharmacy, supramolecular gels, and complement-targeted therapy.

Publications per year

2015–2023

3

Publications

3

Safety and Pharmacokinetics of the Complement Inhibitor TT30 in a Phase I Trial for Untreated PNH Patients

Antonio M. Risitano, Michael Storek, Leonardo Sahelijo et al. · Blood · 2015 · 24 citations

, , +12

Final results of the phase 1/2, open-label clinical study of intravenous recombinant human N-acetyl-α-d-glucosaminidase (SBC-103) in children with mucopolysaccharidosis IIIB

Chester B. Whitley, Suresh Vijay, Bert Yao et al. · Molecular Genetics and Metabolism · 2018 · 24 citations

, , +3

Intranasal Delivery of Endothelial Cell-Derived Extracellular Vesicles with Supramolecular Gel Attenuates Myocardial Ischemia-Reperfusion Injury

Junzhuo Wang, Ying Tan, Yang Dai et al. · International Journal of Nanomedicine · 2023 · 18 citations · Full text

, , +16

1–3 of 3